Martin Siegemund

Martin Siegemund

Company: Pieris Pharmaceuticals

Job title: Senior Scientist


Tumor-Targeted Antibody-Anticalin Bispecifics as Potent Costimulatory Molecules 4:00 pm

Novel costimulators facilitate the generation of multispecific protein formats addressing specific biological modalities Robust and highly selective Anticalin® proteins serving as agonists of costimulatory receptors like 4-1BB Mabcalin™ proteins leverage receptor engagement in immuno-oncology by rational combination with precision targetingRead more

day: Day One

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.